Ludwig Cancer Center Scientist Wins $3 Million Breakthrough Prize for ALS Discovery
Ludwig Cancer Research scientist Don Cleveland has received a $3 million Breakthrough Prize for increasing science’s understanding of how…
Articles by Margarida Azevedo, MSc
Radicava and Its Decisive Phase 3 Trial Among Presentations at ALS/MND Meeting This Weekend
Additional data on Radicava (edaravone) and the clinical trial that led to its approval to treat amyotrophic lateral sclerosis…
Takeda and Montreal Neurological Institute Team Up to Research New ALS Therapies
Takeda Canada and the Montreal Neurological Institute (MNI) are teaming up to conduct joint research aimed at developing…
VA Adds Radicava to its National Formulary for ALS Patients
The U.S. Department of Veterans Affairs (VA) has added Radicava (edaravone) to its national formulary (VANF), making it possible…
NY Students Advance to Siemens Competition Finals with Discovery that Could Aid ALS Research
Four students from New York have been named national finalists in the Siemens Competition in Math, Science and Technology held…
Anthony Senerchia, Who Inspired ALS Ice Bucket Challenge, Dies at 46
Anthony Senerchia Jr., the 46-year-old man who served as the inspiration for the ALS Ice Bucket Challenge, died on…
Muscular Dystrophy Association Awards $3.5M in New Research Grants
The Muscular Dystrophy Association (MDA)Â is financing 13 new research programs aimed at developing treatments for amyotrophic lateral sclerosis…
Neurimmune and Ono Partner to Create Possible ALS Treatments Based on Antibodies
Neurimmune and Ono Pharmaceutical have entered a strategic partnership to develop human-derived monoclonal antibodies that might become the…
Biomarker Test of ALS Progression, Supported by MDA, Expected in US by Year’s End
The Muscular Dystrophy Association (MDA)Â has awarded an MDA Venture Philanthropy (MVP) grant worth $233,200 to Iron Horse…
Option Care, ALS Association Partner to Offer Radicava Home Infusion Services
Option Care Enterprises, a Chicago-based independent provider of home and alternate treatment site infusion services, has partnered with the…